BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37579537)

  • 1. Manganese level and cognitive decline in older adults with the APOE e4 allele: a preliminary study.
    Kim SG; Choe YM; Suh GH; Lee BC; Choi IG; Kim HS; Hwang J; Keum MS; Yi D; Kim JW
    Psychiatry Res; 2023 Sep; 327():115403. PubMed ID: 37579537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
    Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
    Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoarthritis and APOE4 Interact to Influence Memory Decline in Non-Demented Older People.
    Zhou K; Wu P;
    J Alzheimers Dis; 2022; 89(1):79-86. PubMed ID: 35848022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective cognitive decline, APOE e4 allele, and the risk of neurocognitive disorders: Age- and sex-stratified cohort study.
    Liew TM
    Aust N Z J Psychiatry; 2022 Dec; 56(12):1664-1675. PubMed ID: 35229693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
    Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Apolipoprotein E4 on the Driving Behavior of Patients with Amnestic Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia.
    Stanitsa E; Economou A; Beratis I; Kontaxopoulou D; Fragkiadaki S; Papastefanopoulou V; Pavlou D; Papantoniou P; Kroupis C; Papatriantafyllou J; Stefanis L; Yannis G; Papageorgiou SG
    J Alzheimers Dis; 2021; 84(3):1005-1014. PubMed ID: 34602476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Klotho allele status is not associated with Aβ and APOE ε4-related cognitive decline in preclinical Alzheimer's disease.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Ames D; Masters CL; Martins RN; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM
    Neurobiol Aging; 2019 Apr; 76():162-165. PubMed ID: 30716541
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M;
    Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
    McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
    Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired memory-guided attention in asymptomatic APOE4 carriers.
    Zimmermann J; Alain C; Butler C
    Sci Rep; 2019 May; 9(1):8138. PubMed ID: 31148578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Alzheimer disease family history and genetic risk on cognitive performance in healthy middle-aged and older people.
    Donix M; Ercoli LM; Siddarth P; Brown JA; Martin-Harris L; Burggren AC; Miller KJ; Small GW; Bookheimer SY
    Am J Geriatr Psychiatry; 2012 Jul; 20(7):565-73. PubMed ID: 21849821
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Youn YC; Lim YK; Han SH; Giau VV; Lee MK; Park KY; Kim S; Bagyinszky E; An SSA; Kim HR
    Clin Interv Aging; 2017; 12():1095-1102. PubMed ID: 28744113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E4 Allele and Gait Performance in Mild Cognitive Impairment: Results From the Gait and Brain Study.
    Sakurai R; Montero-Odasso M
    J Gerontol A Biol Sci Med Sci; 2017 Nov; 72(12):1676-1682. PubMed ID: 28482102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E genotype impact on memory and attention in older persons: the moderating role of personality phenotype.
    Chapman BP; Benedict RHB; Lin F; Roy S; Porteinsson A; Szigeti K; Federoff H; Mapstone M
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):332-339. PubMed ID: 28612377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease.
    Pievani M; Galluzzi S; Thompson PM; Rasser PE; Bonetti M; Frisoni GB
    Neuroimage; 2011 Apr; 55(3):909-19. PubMed ID: 21224004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
    Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
    Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive trajectories diverge by genetic risk in a preclinical longitudinal cohort.
    Vasiljevic E; Koscik RL; Jonaitis E; Betthauser T; Johnson SC; Engelman CD
    Alzheimers Dement; 2023 Jul; 19(7):3108-3118. PubMed ID: 36723444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between physical activity and episodic memory and the moderating effects of the apolipoprotein E ε4 allele and age.
    Lee BC; Choe YM; Suh GH; Choi IG; Kim HS; Hwang J; Yi D; Kim JW
    Front Aging Neurosci; 2023; 15():1184609. PubMed ID: 37496755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower cerebral oxygen utilization is associated with Alzheimer's disease-related neurodegeneration and poorer cognitive performance among apolipoprotein E ε4 carriers.
    Robb WH; Khan OA; Ahmed HA; Li J; Moore EE; Cambronero FE; Pechman KR; Liu D; Gifford KA; Landman BA; Donahue MJ; Hohman TJ; Jefferson AL
    J Cereb Blood Flow Metab; 2022 Apr; 42(4):642-655. PubMed ID: 34743630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.